Latest News

Touch Bionics sales reach £12.3 million in 2013

Touch Bionics today announced that preliminary results indicate the company achieved revenue growth of 23% in 2013 to reach £12.3m in total sales. 

The company's growth was driven by the introduction of the i-limb ultra revolution, the most advanced bionic hand solution available for patients with upper limb deficiencies. The company also introduced biosim and my i-limb mobile apps, which enable clinicians and patients to easily program the features of an i-limb via a handheld mobile device.

"We are pleased with our 2013 performance and are looking forward to continued growth in 2014," said Ian Stevens, CEO, Touch Bionics. "Patients have benefitted from recent enhancements to our technologies, which can restore significant function and self esteem following the trauma of upper limb loss."